Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Maria Queralt Salas"'
Autor:
Sonia Ruiz-Boy, Alexandra Pedraza, Marta Prat, Maria Queralt Salas, Esther Carcelero, Gisela Riu-Viladoms, María Suárez-Lledó, Inés Monge-Escartín, Luis Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, Montserrat Rovira, Carmen Martínez, Cristina Gallego, Álvaro Urbano-Ispizua, Joan Sánchez, María Ángeles Marcos, Francesc Fernández-Avilés
Publikováno v:
Pharmaceuticals, Vol 16, Iss 12, p 1741 (2023)
Cytomegalovirus (CMV) infection is a relevant cause of morbimortality in patients receiving allogeneic stem cell transplantation (allo-HCT). Foscarnet (FCN) is an effective drug against CMV administered intravenously and usually on an inpatient basis
Externí odkaz:
https://doaj.org/article/7f1d8a9fa215409198a98d3f252d56b2
Autor:
Maria Queralt Salas, Alberto Mussetti, Carme Muñóz, Adaia Albasanz-Puig, Beatriz Patiño, Laura Jimenez Prat, Carlota Gudiol, Rocío Parody, Anna Sureda
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss 3, Pp 440-443 (2022)
Externí odkaz:
https://doaj.org/article/40dc9b60f9274efead99b3a136c86013
Autor:
Maria Condom, Alberto Mussetti, Clara Maluquer, Rocío Parody, Eva González‐Barca, Montserrat Arnan, Adaia Albasanz‐Puig, Helena Pomares, Maria Queralt Salas, Itziar Carro, Marta Peña, Victòria Clapes, Cristina Baca Cano, Ana Carla Oliveira Ramos, Gabriela Sanz‐Linares, Gabriel Moreno‐González, Santiago Mercadal, Concepcion Boqué, Carlota Gudiol, Eva Domingo‐Domènech, Anna Sureda
Publikováno v:
Cancer Reports, Vol 4, Iss 4, Pp n/a-n/a (2021)
Abstract Background Clinical outcomes of novel coronavirus 2019 disease (COVID‐19) in onco‐hematological patients are unknown. When compared to non‐immunocompromised patients, onco‐hematological patients seem to have higher mortality rates. A
Externí odkaz:
https://doaj.org/article/b199fbf0402549ec9e8d7cc78f8eda23
Autor:
Maria Queralt Salas, Arjun Datt Law, Wilson Lam, Zeyad Al-Shaibani, David Loach, Dennis (Dong Hwan) Kim, Fotios V. Michelis, Santhosh Thyagu, Rajat Kumar, Jeffrey Howard Lipton, Jonas Mattsson, Auro Viswabandya
Publikováno v:
Clinical Hematology International, Vol 1, Iss 2 (2019)
Haploidentical stem cell transplantation (haploSCT) has greatly improved access to curative treatment for myeloid malignancies in patients without suitable matched sibling/unrelated donors. We investigated the safety and efficacy of haploSCT after re
Externí odkaz:
https://doaj.org/article/d1fb35b8e0cd4c28aa1183db06145608
Autor:
Maria Queralt Salas, Abel Santos Carreira, Eshetu G. Atenafu, Tommy Alfaro Moya, Arjun D. Law, Wilson Lam, Ivan Pasic, Carol Chen, Dennis Dong Hwan Kim, Fotios V. Michelis, Armin Gerbitz, Jeffrey H. Lipton, Rajat Kumar, Jonas Mattsson, Auro Viswabandya
Publikováno v:
Blood. 140:7625-7627
Autor:
Marta Gómez-Hernando, Luis F. Quintana, María Suárez-Lledo, Nuria Martínez-Cibrian, Andrea Rivero, Sonia Ruiz-Boy, Ester Carcelero, Paula Mate, Gisela Riu, Inés Monge, Anna Serrahima, Maria Teresa Solano, Laura Rosiñol, Jordi Esteve, Alvaro Urbano-Ispizua, Enric Carreras, Francesc Fernández-Avilés, Carmen Martínez, Montserrat Rovira, Maria Queralt Salas
Publikováno v:
Bone Marrow Transplantation. 58:212-214
Autor:
Tania Jain, Noel Estrada-Merly, Soyoung Kim, Maria Queralt Salas, Marcio Andrade Campos, Hany Elmariah, Rajat Kumar, Nelli Bejanyan, Richard J Jones, Taiga Nishihori, Dr. Betul Oran, Ryotaro Nakamura, Bart L. Scott, Vikas Gupta, Wael Saber
Publikováno v:
Transplantation and Cellular Therapy. 29:S8-S9
Autor:
Jeffrey H. Lipton, Jonas Mattsson, Shiyi Chen, Auro Viswabandya, Maria Queralt Salas, Shruti Prem, Arjun Law, Fotios V. Michelis, Wilson Lam, Vikas Gupta, Sunu Cyriac, Rajat Kumar, Dennis Dong Hwan Kim, Zeyad Al-Shaibani
Publikováno v:
European Journal of Haematology. 107:517-528
Allogeneic hematopoeitic cell transplantation (allo-HCT) is the only curative treatment for myelofibrosis (MF). We evaluate the impact of various factors on survival outcomes post-transplant in MF. Data of 89 consecutive MF patients (primary 47%) who
Autor:
Luis Gerardo Rodríguez-Lobato, Oriol Cardus, Joan Mañe-Pujol, Anthony M Battram, Lorena Pérez-Amill, Hugo Calderón, Beatriz Martin-Antonio, Aina Oliver-Caldes, Agnès Garcias-López, Ester Lozano, David F. Moreno, Valentín Ortiz-Maldonado, Maria Queralt Salas, Anna de Daniel i Bisbe, Natalia Tovar, Raquel Jiménez-Segura, M. Teresa Cibeira, Laura Rosinol Dachs, Joan Bladé Creixenti, Manel Juan, Álvaro Urbano-Ispizua, Pablo Engel, Carlos Fernandez de Larrea
Publikováno v:
Blood. 140:10281-10282
Autor:
Maria Queralt Salas, Eshetu G. Atenafu, Ivan Pasic, Eshrak Al-Shaibani, Ora Bascom, Leeann Wilson, Carol Chen, Arjun Datt Law, Wilson Lam, Igor Novitzky-Basso, Dennis Kim, Armin Gerbitz, Auro Viswabandya, Fotios V. Michelis, Jeffrey Howard Lipton, Jonas Mattsson, Shabbir Alibhai, Rajat Kumar
Publikováno v:
Bone marrow transplantation.
This prospective study designs an HCT Frailty Scale to classify alloHCT candidates into groups of frail, pre-frail, and fit, and to be implemented in the first consultation at no additional cost. The present scale is composed of the following eight v